Literature DB >> 870186

Cytotoxic effects of interferon in vitro on granulocytic progenitor cells.

P L Greenberg, S A Mosny.   

Abstract

We have utilized in vitro marrow culture techniques to evaluate the cytotoxicity for granulocytic progenitor cells of two highly purified human leukocyte interferon preparations. Concentration- and time-related decrements in granulocytic colony-forming capacity in agar occurred with human and mouse marrow. Although mouse marrow cells were less sensitive than were human cells, these data indicate lack of strict species specificity for the cell growth-inhibitory effects of interferon. Similar cytotoxicity was noted for normal and leukemic human clonogenic cells exposed to interferon for prolonged periods. The decrease in the proportion of granulocytic progenitor cells in DNA synthesis, which occurred at high concentrations, and the diminution by interferon of the cytotoxicity caused by cytosine arabinoside demonstrate that interferon decreases DNA synthesis of granulocytic progenitor cells. The lack of enhanced cytotoxicity for rapidly proliferating mouse post-endotoxin marrow cells indicates that interferon is not a cell cycle-stage-specific drug. These data seem useful for evaluating the suppressive effects of interferon on granulopoiesis and for devising clinical trials with this agent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870186

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Innate immune stimuli modulate bone marrow-derived dendritic cell production in vitro by toll-like receptor-dependent and -independent mechanisms.

Authors:  Joan E Downes; Stuart Marshall-Clarke
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

Review 2.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression.

Authors:  M Trucco; S Shaw; R Korngold
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 4.  [Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl)].

Authors:  E Heidemann
Journal:  Klin Wochenschr       Date:  1980-10-15

Review 5.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 6.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

7.  Interferon induction in swine lymphocyte antigen-defined miniature pigs.

Authors:  L T Jordan; J B Derbyshire; B A Mallard
Journal:  Res Vet Sci       Date:  1995-05       Impact factor: 2.534

8.  Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML).

Authors:  A Z Rohatiner; F R Balkwill; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.

Authors:  H Ludwig; W Linkesch; H Gisslinger; E Fritz; H Sinzinger; T Radaszkiewicz; A Chott; R Flener; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination.

Authors:  G Visani; D Russo; D Damiani; S Rizzi; M R Motta; R M Lemoli; C Poluzzi; R Fanin; E Zuffa; P Tosi
Journal:  Blut       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.